Monocyte-Derived Human Dendritic Cells Function of the CD49d Integrin on Maturation-Dependent Expression and

Teixido, Carmelo Bernabeu and Angel L. CorbiLongo, Paloma Sanchez-Mateos, Luisa Botella, Joaquin Amaya Puig-Kroger, Francisco Sanz-Rodriguez, Natividadhttp://www.jimmunol.org/content/165/8/4338J Immunol€2000; 165:4338-4345; ;Referenceshttp://www.jimmunol.org/content/165/8/4338.full#ref-list-1This article cites 44 articles, 15 of which you can access for free at: Subscriptionshttp://jimmunol.org/subscriptionsInformation about subscribing to The Journal of Immunology is online at: Permissionshttp://www.aai.org/ji/copyright.htmlSubmit copyright permission requests at: Email Alertshttp://jimmunol.org/cgi/alerts/etocReceive free email-alerts when new articles cite this article. Sign up at:

[1]  Josephine C. Adams,et al.  Fibronectin inhibits the terminal differentiation of human keratinocytes , 1989, Nature.

[2]  J. Mandel,et al.  The glyceraldehyde 3 phosphate dehydrogenase gene family: structure of a human cDNA and of an X chromosome linked pseudogene; amazing complexity of the gene family in mouse. , 1984, The EMBO journal.

[3]  M J Bissell,et al.  A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. , 1995, Current opinion in cell biology.

[4]  Richard O. Hynes,et al.  Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor α 4 β 1 , 1990, Cell.

[5]  A. Lazarovits,et al.  Specific regulation of VLA-4 and alpha 4 beta 7 integrin expression on human activated T lymphocytes. , 1996, Journal of immunology.

[6]  A. Bridges,et al.  A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Elices,et al.  VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site , 1990, Cell.

[8]  W. V. Berghe,et al.  N-Acetyl-l-Cysteine Inhibits Primary Human T Cell Responses at the Dendritic Cell Level: Association with NF-κB Inhibition , 1999, The Journal of Immunology.

[9]  Katsuaki Sato,et al.  Extracellular signal-regulated kinase, stress-activated protein kinase/c-Jun N-terminal kinase, and p38mapk are involved in IL-10-mediated selective repression of TNF-alpha-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells. , 1999, Journal of immunology.

[10]  Klaus Resch,et al.  The p38 MAP kinase pathway signals for cytokine‐induced mRNA stabilization via MAP kinase‐activated protein kinase 2 and an AU‐rich region‐targeted mechanism , 1999, The EMBO journal.

[11]  M. Hemler,et al.  The pathophysiologic role of alpha 4 integrins in vivo. , 1994, The Journal of clinical investigation.

[12]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[13]  D. Dean,et al.  c‐Myb and Ets proteins synergize to overcome transcriptional repression by ZEB , 1997, The EMBO journal.

[14]  S. Nilsson,et al.  Adhesion receptor expression by hematopoietic cell lines and murine progenitors: modulation by cytokines and cell cycle status. , 1999, Experimental hematology.

[15]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[16]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[17]  M. Elices,et al.  The primary structure of the alpha 4 subunit of VLA‐4: homology to other integrins and a possible cell‐cell adhesion function. , 1989, The EMBO journal.

[18]  H. Mischak,et al.  CpG‐DNA‐specific activation of antigen‐presenting cells requires stress kinase activity and is preceded by non‐specific endocytosis and endosomal maturation , 1998, The EMBO journal.

[19]  S. Nakagawa,et al.  Up-regulation of α4 integrin on activated langerhans cells: Analysis of adhesion molecules on langerhans cells relating to their migration from skin to draining lymph nodes , 1993 .

[20]  R. Steinman,et al.  Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. , 1996, Journal of immunological methods.

[21]  S. Matsuda,et al.  Synergistic Effects of IL-4 and IL-18 on IL-12-Dependent IFN-γ Production by Dendritic Cells1 , 2000, The Journal of Immunology.

[22]  C. Caux,et al.  Dendritic Cell Development: Multiple Pathways to Nature's Adjuvants , 1997, Stem cells.

[23]  P. Ricciardi-Castagnoli,et al.  Dendritic cells hold promise for immunotherapy. , 1997, Immunology today.

[24]  J. Banchereau,et al.  CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha , 1996, The Journal of experimental medicine.

[25]  J. Sanes,et al.  Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis , 1992, Cell.

[26]  K. Terao,et al.  Selective expression of beta 7 integrin on lymphocytes undergoing apoptosis in lymphoid tissues. , 1998, Biochemical and biophysical research communications.

[27]  D. Hart,et al.  Dendritic cells: unique leukocyte populations which control the primary immune response. , 1997, Blood.

[28]  Philip R. Cohen,et al.  SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1 , 1995, FEBS letters.

[29]  R. Steinman,et al.  Myeloid dendritic cells , 1999, Journal of leukocyte biology.

[30]  D. Sheppard,et al.  Complete amino acid sequence of an integrin beta subunit (beta 7) identified in leukocytes. , 1991, The Journal of biological chemistry.

[31]  F. Sánchez‐Madrid,et al.  Functional Evidence for Three Distinct and Independently Inhibitable Adhesion Activities Mediated by the Human Integrin VLA-4 , 1991 .

[32]  I. Mellman,et al.  Defective IL‐12 production in mitogen‐activated protein (MAP) kinase kinase 3 (Mkk3)‐deficient mice , 1999, The EMBO journal.

[33]  E. Berg,et al.  α4 integrins mediate lymphocyte attachment and rolling under physiologic flow , 1995, Cell.

[34]  I. Cotgreave,et al.  N-acetylcysteine: pharmacological considerations and experimental and clinical applications. , 1997, Advances in pharmacology.

[35]  F. Sallusto,et al.  Origin, maturation and antigen presenting function of dendritic cells. , 1997, Current opinion in immunology.

[36]  E. Clark,et al.  Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. , 1999, Journal of immunology.

[37]  M. Rubio,et al.  Monocyte activation: rapid induction of α1/β1 (VLA‐1) integrin expression by lipopolysaccharide and interferon‐γ , 1995, European journal of immunology.

[38]  A. Enk,et al.  Influence of extracellular matrix proteins on the development of cultured human dendritic cells , 1998, European journal of immunology.

[39]  Á. Corbí,et al.  Regulated expression of p150,95 (CD11c/CD18; αX/β2) and VLA‐4 (CD49d/CD29; α4/β1) integrins during myeloid cell differentiation , 1994 .

[40]  D. Niederwieser,et al.  Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. , 1996, Journal of immunological methods.

[41]  I. Mellman,et al.  CHAPTER 16 – Studies of endocytosis , 2001 .

[42]  ICAMs Redistributed by Chemokines to Cellular Uropods as a Mechanism for Recruitment of T Lymphocytes , 1997 .